We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Janssen-Cilag has announced the French health authority Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), has approved Eprex (epoetin alfa) for the treatment of symptomatic anaemia.